Simvastatin
ZOCOR
HMG-CoA Reductase Inhibitor
NADAC/unit
$0.0281
No Shortage
Tier 1: 369.9%
PA Req: 1.5%
11 Manufacturers
54 ANDAs
Simvastatin lowers LDL cholesterol and triglycerides to reduce cardiovascular risk.
vs. brand ZOCOR: Generic saves up to 100% per unit
Market Intelligence
2023-03-08 Class II Recall: Accord Healthcare, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCAUROBINDO PHARMA LTDBIOCON PHARMA LTDHETERO LABS LTD UNIT IIIINVAGEN PHARMACEUTICALS INCLUPIN LTDMICRO LABS LTDORGANON LLC A SUB OF ORGANON AND COOXFORD PHARMACEUTICALS LLCRISING PHARMA HOLDINGS INCSALERNO PHARMACEUTICALSYILING PHARMACEUTICAL LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.